RSS   Newsletter   Contact   Advertise with us
Post Online Media

Retrophin names John A. Orwin to board

RetrophinRetrophin, a biopharmaceutical company, announced the appointment of John A. Orwin to the company’s board of directors.

Mr. Orwin is a biopharmaceutical industry veteran with more than 25 years of experience. He has served as chief executive officer of Relypsa since 2013.

READ MORE Retrophin appoints Roy D. Baynes to board

Previously, Mr. Orwin was chief executive officer and a director of Affymax.

Before joining Affymax, he held leadership positions in marketing, sales, and operations at Genentech, Johnson and Johnson, Alza Pharmaceuticals, Sangstat Medical Corporation, Rhone-Poulenc Rorer, and Schering-Plough.

Mr. Orwin currently serves as a director of Seattle Genetics and Array BioPharma.

Mr. Orwin earned a bachelor’s degree from Rutgers University and master’s degree in business administration from New York University.


More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy